Nepafenac-associated bilateral corneal melt after photorefractive keratectomy

Cornea. 2009 Sep;28(8):948-50. doi: 10.1097/ICO.0b013e318199e9cc.

Abstract

Purpose: We are reporting a case of bilateral corneal melt after photorefractive keratectomy requiring bilateral corneal transplantations.

Results: A 35-year-old man underwent uncomplicated photorefractive keratectomy and was treated postoperatively with topical nepafenac, one drop in both eyes every 2 hours. Three days into this course of treatment, the patient developed bilateral irritation and the dose was decreased to one drop every 4 hours. The next day, he developed stromal melting in both eyes. Although nepafenac was discontinued at this point, the ulcerative keratolysis progressed in both eyes requiring penetrating keratoplasty.

Conclusions: We report a case of sterile ulceration after photorefractive keratectomy surgery, which we believe was caused by frequent postoperative dosing of nepafenac.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Benzeneacetamides / administration & dosage*
  • Benzeneacetamides / adverse effects*
  • Corneal Stroma
  • Corneal Ulcer / etiology*
  • Corneal Ulcer / pathology
  • Corneal Ulcer / surgery
  • Drug Administration Schedule
  • Humans
  • Keratoplasty, Penetrating
  • Male
  • Phenylacetates / administration & dosage*
  • Phenylacetates / adverse effects*
  • Photorefractive Keratectomy*
  • Postoperative Care*
  • Reoperation

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Benzeneacetamides
  • Phenylacetates
  • nepafenac